The global market for cardiovascular surgery devices was valued at $2 billion in 2009, and is forecast to grow at a Compound Annual Growth Rate (CAGR) of 3% to reach $2.4 billion in 2016. The market is expected to be driven by patient population suffering from Coronary Artery Disease (CAD) and their increased awareness and safety of cardiovascular surgery over Percutaneous Coronary Intervention (PCI) in some cases, such as three vessel coronary artery disease.

Read the full story here